References
- Amit M, Tam S, Bader T, Sorkin A, Benov A. Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2 pandemic: should we revisit the recommendations? Eur J Cancer 2020; 134: 86-9. doi: 10.1016/j.ejca.2020.04.016
- Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo OC. Breast cancer diagnosis in coronavirus-era: alert from italy. Frontiers Oncol 2020; 10: 938. doi: 10.3389/fonc.2020.00938
- Vrdoljak E, Sullivan R, Lawler M. Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? Eur J Cancer 2020; 132: 98-9. doi: 10.1016/j.ejca.2020.04.001
- Ordinance on interim measures in the field of health activities to contain and control the COVID-19 epidemic.[Slovenian]. Uradni list Republike Slovenije 32/20; Ljubljana; 2020. [cited 2020 Jun 30]. Available at https://www.uradni-list.si/glasilo-uradni-list-rs/vsebina/2020-01-0645/odlok-ozacasnih-ukrepih-na-podrocju-zdravstvene-dejavnosti-zaradi-zajezitve-inobvladovanja-epidemije-covid-19
- Del Vecchio Blanco G, Calabrese E, Biancone L, Monteleone G, Paoluzi OA. The impact of COVID-19 pandemic in the colorectal cancer prevention. Int J Colorectal Dis 2020; [Ahead of print] 4 Jun 2020. doi:10.1007/s00384-020-03635-6
- World Health Organization. Rapid assessment of service delivery for NCDs during COVID-19 pandemic Geneva; 2020.
- Fong D, Rauch S, Petter C, Haspinger E, Alber M, Mitterer M. Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy. ESMO Open 2020; 5: e000810. doi: 10.1136/esmoopen-2020-000810
- van de Haar J, Hoes LR, Coles CE, Seamon K, Fröhling S, Jäger D, et al. Caring for patients with cancer in the COVID-19 era. Nat Med 2020; 26: 665-71. doi: 10.1038/s41591-020-0874-8
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-7. doi: 10.1016/S1470-2045(20)30096-6
- Restivo A, De Luca R, Spolverato G, Delrio P, Lorenzon L, D’Ugo D, et al. The need of COVID19 free hospitals to maintain cancer care. Eur J Surg Oncol 2020; 46: 1186-7. doi: 10.1016/j.ejso.2020.04.003
- Mahase E. Covid-19: cancer research urges mass testing to enable care to continue during pandemic. BMJ 2020; 369: m1561. doi: 10.1136/bmj.m1561
- Earnshaw CH, Hunter HJA, McMullen E, Griffiths CEM, Warren RB. Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic. Br J Dermatol 2020; [Ahead of print] 4 Jun 2020. doi:10.1111/bjd.19267
- Mahase E. Covid-19: Urgent cancer referrals fall by 60%, showing “brutal” impact of pandemic. BMJ 2020; 369: m2386. doi: 10.1136/bmj.m2386
- Minucci A, Scambia G, Santonocito C, Concolino P, Urbani A. BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic. Mol Biol Rep 2020; 47: 4857-60. doi: 10.1007/s11033-020-05479-3
- Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 2020; 21: 750-1. doi: 10.1016/S1470-2045(20)30265-5
- De Vincentiis L, Carr RA, Mariani MP, Ferrara G. Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology. J Clin Pathol 2020; [Ahead of print] 19 June 2020. doi: 10.1136/jclinpath-2020-206833
- Mehrotra A, Chernew M, Linetsky D, Hatch H, Cutler D. The impact of the COVID-19 pandemic on outpatient visits: a rebound emerges. To the Point (blog), Commonwealth Fund 2020; Published Online First: 19 May 2020. [cited 2020 Jun 30]. Available at: https://www.commonwealthfund.org/publications/2020/apr/impact-covid-19-outpatient-visits doi: https://doi.org/10.26099/ds9e-jm36
- Sharpless NE. COVID-19 and cancer. Science 2020; 368: 1290. doi: 10.1126/science.abd3377